Skip Nav Destination
Issues
15 September 2010
-
Cover Image
Cover Image
Clinical Use of γH2AX and PAR: Image of an anagen hair bulb plucked from the scalp of a cancer patient 24 hours after drug infusion. γH2AX antibody reveals DNA double-strand breaks (green foci) in cell nuclei (red). Imaged using a Nikon PCM 2000 laser scanning confocal microscope. For details, please see the article by Redon and colleagues on p. 4532 of this issue. - PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
Highlights
CCR Translations
Molecular Pathways
CCR Focus
Human Cancer Biology
Regulation of Excision Repair Cross-Complementation Group 1 by Snail Contributes to Cisplatin Resistance in Head and Neck Cancer
Dennis Shin-Shian Hsu; Hsin-Yi Lan; Chi-Hung Huang; Shyh-Kuan Tai; Shyue-Yih Chang; Tung-Lung Tsai; Cheng-Chi Chang; Cheng-Hwai Tzeng; Kou-Juey Wu; Jung-Yie Kao; Muh-Hwa Yang
System-Level Analysis of Neuroblastoma Tumor–Initiating Cells Implicates AURKB as a Novel Drug Target for Neuroblastoma
Olena Morozova; Milijana Vojvodic; Natalie Grinshtein; Loen M. Hansford; Kim M. Blakely; Alexandra Maslova; Martin Hirst; Timothee Cezard; Ryan D. Morin; Richard Moore; Kristen M. Smith; Freda Miller; Paul Taylor; Nina Thiessen; Richard Varhol; Yongjun Zhao; Steven Jones; Jason Moffat; Thomas Kislinger; Michael F. Moran; David R. Kaplan; Marco A. Marra
Cancer Therapy: Preclinical
Imaging, Diagnosis, Prognosis
Impact of Serum Hepatocyte Growth Factor on Treatment Response to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Non–Small Cell Lung Adenocarcinoma
Kazuo Kasahara; Tokuzo Arao; Kazuko Sakai; Kazuko Matsumoto; Asao Sakai; Hideharu Kimura; Takashi Sone; Atsushi Horiike; Makoto Nishio; Tatsuo Ohira; Norihiko Ikeda; Takeharu Yamanaka; Nagahiro Saijo; Kazuto Nishio
Jumonji Domain Containing 1A Is a Novel Prognostic Marker for Colorectal Cancer: In vivo Identification from Hypoxic Tumor Cells
Mamoru Uemura; Hirofumi Yamamoto; Ichiro Takemasa; Koshi Mimori; Hideyuki Hemmi; Tsunekazu Mizushima; Masataka Ikeda; Mitsugu Sekimoto; Nariaki Matsuura; Yuichiro Doki; Masaki Mori
Cancer Therapy: Clinical
Molecular Analysis of Non–Small Cell Lung Cancer Identifies Subsets with Different Sensitivity to Insulin-like Growth Factor I Receptor Inhibition
Antonio Gualberto; Marisa Dolled-Filhart; Mark Gustavson; Jason Christiansen; Yu-Fen Wang; Mary L. Hixon; Jennifer Reynolds; Sandra McDonald; Agnes Ang; David L. Rimm; Corey J. Langer; Johnetta Blakely; Linda Garland; Luis G. Paz-Ares; Daniel D. Karp; Adrian V. Lee
Correction
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds